"10.1371_journal.pone.0143259","plos one","2015-11-24T00:00:00Z","Joseph B Margolick; Linda Apuzzo; Joel Singer; Hubert Wong; Terry Lee; Joel E Gallant; Phillippe El-Helou; Mona R Loutfy; Anita Rachlis; Christopher Fraser; Kenneth Kasper; Cécile Tremblay; Harout Tossonian; Brian Conway","Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America; CIHR Canadian HIV Trials Network, Vancouver, British Columbia, Canada; Department of Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland, United States of America; Department of Medicine, McMaster University, Hamilton, Ontario Canada; Maple Leaf Medical Clinic, Toronto, Ontario, Canada; Sunnybrook Health Sciences, Toronto, Ontario, Canada; Cool Aid Community Health Center, Victoria, British Columbia, Canada; Department of Medical Microbiology, University of Manitoba, Winnipeg, Manitoba, Canada; Centre de recherché du Centre Hospitalier de l’ Université de Montréal, Montréal, Quebec, Canada; Vancouver Infectious Diseases Centre, Vancouver, British Columbia, Canada","Conceived and designed the experiments: JM JS HW JG BC. Performed the experiments: JM LA JG PE-H ML AR CF KK CT HT BC. Analyzed the data: JS HW TL. Wrote the paper: JM LA JS HW TL JG PE-H ML AR CF KK CT HT BC.","The authors have read the journals policy and one author of this manuscript has the following competing interest: Gilead Sciences, GlaxoSmithKline, Bristol-Myers Squibb, and Abbott Laboratories provided antiretroviral medications for this study and additional financial support was provided by Janssen Therapeutics. Gallant: AbbVie (research support), Bristol-Myers Squibb (research support and scientific advisory board), Gilead Sciences (research support and scientific advisory board), Janssen Therapeutics (research support and scientific advisory board), Merck & Co. (research support and scientific advisory board), Sangamo BioSciences (research support), ViiV Healthcare (research support and scientific advisory board). There are no patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2015","11","Joseph B Margolick","JBM",14,TRUE,5,11,3,14,TRUE,FALSE,FALSE,0,NA,FALSE
